Lower urinary tract symptoms, benign prostatic hyperplasia, and obesity

Current Urology Reports

Volumn 10, Issue 4, 2009, Pages 247-253

  McVary, Kevin T ^a   Mongiu, Anne K ^b  

^a NORTHWESTERN UNIVERSITY   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BODY MASS; CANCER RISK; DISEASE ASSOCIATION; DNA POLYMORPHISM; GENE EXPRESSION; HUMAN; LIFESTYLE MODIFICATION; OBESITY; PHYSICAL ACTIVITY; PREVALENCE; PROSTATE; PROSTATE HYPERTROPHY; PUBLIC HEALTH; REVIEW; RISK FACTOR; SYMPTOM; UNITED STATES; URINARY TRACT; URINARY TRACT DISEASE; URINARY TRACT FUNCTION;

HUMANS; MALE; OBESITY; PROSTATIC HYPERPLASIA; PROSTATISM; RISK FACTORS;

EID: 68149148512     PISSN: 15272737     EISSN: 15346285     Source Type: Journal    
DOI: 10.1007/s11934-009-0041-8     Document Type: Review

References (51)

1. Z. Xia R.O. Roberts D. Schottenfeld 1999 Trends in prostatectomy for benign prostatic hyperplasia among black and white men in the United States: 1980 to 1994 Urology 53 1154 1159 (Pubitemid 29264746)
2. J.T. Wei E. Calhoun S.J. Jacobsen 2005 Urologic diseases in America project: benign prostatic hyperplasia J Urol 173 1256 1261 (Pubitemid 40380548)
3. T.B. Harbitz O.A. Haugen 1972 Histology of the prostate in elderly men. A study in an autopsy series Acta Pathol Microbiol Scand [A] 80 756 768
4. S.J. Berry D.S. Coffey P.C. Walsh L.L. Ewing 1984 The development of human benign prostatic hyperplasia with age J Urol 132 474 479 (Pubitemid 14026148)
5. J.W. Logie G.M. Clifford R.D. Farmer B.P. Meesen 2001 Lower urinary tract symptoms suggestive of benign prostatic obstruction-Triumph: the role of general practice databases Eur Urol 39 Suppl3 42 47 (Pubitemid 32280783)
6. H.A. Guess H.M. Arrighi E.J. Metter J.L. Fozard 1990 Cumulative prevalence of prostatism matches the autopsy prevalence of benign prostatic hyperplasia Prostate 17 241 246
7. M.J. Barry F.J. Fowler Jr L. Bin 1997 The natural history of patients with benign prostatic hyperplasia as diagnosed by North American urologists J Urol 157 10 14
8. S.J. Jacobsen C.J. Girman H.A. Guess 1996 Natural history of prostatism: longitudinal changes in voiding symptoms in community dwelling men J Urol 155 595 600 (Pubitemid 26023551)
9. J.C. Nickel J. Downey I. Young S. Boag 1999 Asymptomatic inflammation and/or infection in benign prostatic hyperplasia BJU Int 84 976 981
10. S. Rohrmann M.D. Fallin W.F. Page 2006 Concordance rates and modifiable risk factors for lower urinary tract symptoms in twins Epidemiology 17 419
11. A.W. Partin W.F. Page B.R. Lee 1994 Concordance rates for benign prostatic disease among twins suggest hereditary influence Urology 44 646 650
12. A.R. Kristal K.B. Arnold J.M. Schenk 2007 Race/ethnicity, obesity, health related behaviors and the risk of symptomatic benign prostatic hyperplasia: results from the prostate cancer prevention trial J Urol 177 1395 1400 (Pubitemid 46436001)
13. Rotkin I: Epidemiology of benign prostatic hypertrophy: review and speculations. Presented at Benign Prostatic Hyperplasia: NIAMDD Workshop Proceedings. February 20-21, 1975.
14. M.G. Sanda T.H. Beaty R.E. Stutzman 1994 Genetic susceptibility of benign prostatic hyperplasia J Urol 152 115 119 (Pubitemid 24175715)
15. S. Kasturi S. Russell K.T. [tmp] McVary 2006 Metabolic syndrome and lower urinary tract symptoms secondary to benign prostatic hyperplasia Curr Urol Rep 7 288 292 (Pubitemid 44623991)
16. C.L. Ogden M.D. Carroll L.R. Curtin 2006 Prevalence of overweight and obesity in the United States, 1999-2004 JAMA 295 1549 1555
17. R.H. Eckel S.M. Grundy P.Z. Zimmet 2005 The metabolic syndrome Lancet 365 1415 1428 (Pubitemid 40523737)
18. N.T. Nguyen C.P. Magno K.T. Lane 2008 Association of hypertension, diabetes, dyslipidemia, and metabolic syndrome with obesity: findings from the National Health and Nutrition Examination Survey, 1999 to 2004 J Am Coll Surg 207 928 934
19. E.S. Ford W.H. Giles W.H. Dietz 2002 Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey JAMA 287 356 359 (Pubitemid 34251969)
20. R.J. Glynn E.W. Campion G.R. Bouchard J.E. Silbert 1985 The development of benign prostatic hyperplasia among volunteers in the Normative Aging Study Am J Epidemiol 121 78 90 (Pubitemid 15150691)
21. S. Rohrmann E. Smit E. Giovannucci E.A. Platz 2004 Associations of obesity with lower urinary tract symptoms and noncancer prostate surgery in the Third National Health and Nutrition Examination Survey Am J Epidemiol 159 390 397 (Pubitemid 38200773)
22. M.A. Joseph S.D. Harlow J.T. Wei 2003 Risk factors for lower urinary tract symptoms in a population-based sample of African-American men Am J Epidemiol 157 906 914 (Pubitemid 36555050)
23. J. Hammarsten B. Hogstedt 2001 Hyperinsulinaemia as a risk factor for developing benign prostatic hyperplasia Eur Urol 39 151 158 (Pubitemid 32171181)
24. K. Tamakoshi H. Yatsuya T. Kondo 2003 The metabolic syndrome is associated with elevated circulating C-reactive protein in healthy reference range, a systemic low-grade inflammatory state Int J Obes Relat Metab Disord 27 443 449 (Pubitemid 36520842)
25. S.E. Dahle A.P. Chokkalingam Y.T. Gao 2002 Body size and serum levels of insulin and leptin in relation to the risk of benign prostatic hyperplasia J Urol 168 599 604 (Pubitemid 34793304)
26. H. Nandeesha B.C. Koner L.N. Dorairajan S.K. Sen 2006 Hyperinsulinemia and dyslipidemia in non-diabetic benign prostatic hyperplasia Clinica Chimica Acta 370 89 93 (Pubitemid 44080171)
27. J.K. Parsons J. Bergstrom E. Barrett-Connor 2008 Lipids, lipoproteins and the risk of benign prostatic hyperplasia in community-dwelling men BJU International 101 313 318
28. B.A. Laven N. Orsini S.O. Andersson 2008 Birth weight, abdominal obesity and the risk of lower urinary tract symptoms in a population based study of Swedish men J Urol 179 1891 1895
29. J.K. Parsons H.B. Carter A.W. Partin 2006 Metabolic factors associated with benign prostatic hyperplasia J Clin Endocrinol Metab 91 2562 2568 (Pubitemid 44024618)
30. S. Rohrmann E. Smit E. Giovannucci E.A. Platz 2005 Association between markers of the metabolic syndrome and lower urinary tract symptoms in the Third National Health and Nutrition Examination Survey (NHANES III) Int J Obes (Lond) 29 310 316 (Pubitemid 40333230)
31. C. Ozden O.L. Ozdal G. Urgancioglu 2007 The correlation between metabolic syndrome and prostatic growth in patients with benign prostatic hyperplasia Eur Urol 51 199 206 (Pubitemid 44821513)
32. A. Gupta S. Gupta M. Pavuk C.G. Roehrborn 2006 Anthropometric and metabolic factors and risk of benign prostatic hyperplasia: a prospective cohort study of Air Force veterans Urology 68 1198 1205 (Pubitemid 44880381)
33. H.K. Park H.W. Lee K.S. Lee 2008 Relationship between lower urinary tract symptoms and metabolic syndrome in a community-based elderly population Urology 72 556 560
34. D.M. Peehl 1996 The role of insulin-like growth factors in prostate biology J Androl 17 2 4 (Pubitemid 26090524)
35. S. Rohrmann E. Giovannucci E. Smit E.A. Platz 2007 Association of IGF-1 and IGFBP-3 with lower urinary tract symptoms in the third national health and nutrition examination survey Prostate 67 1693 1698 (Pubitemid 350036955)
36. M.L. Neuhouser J. Schenk Y.J. Song 2008 Insulin-like growth factor-I, insulin-like growth factor binding protein-3and risk of benign prostate hyperplasia in the prostate cancer prevention trial Prostate 68 1477 1486
37. Maserejian NN, Giovannucci EL, McKinlay JB: Dietary macronutrients, cholesterol, and sodium and lower urinary tract symptoms in men. Eur Urol 2008 Aug 3 (Epub ahead of print).
38. A.R. Kristal K.B. Arnold J.M. Schenk 2008 Dietary patterns, supplement use, and the risk of symptomatic benign prostatic hyperplasia: results from the prostate cancer prevention trial Am J Epidemiol 167 925 934
39. K.T. [tmp] McVary A. Razzaq C. Lee 1994 Growth of the rat prostate gland is facilitated by the autonomic nervous system Biol Reprod 51 99 107 (Pubitemid 24179226)
40. K.T. [tmp] McVary A. Rademaker G.L. Lloyd P. Gann 2005 Autonomic nervous system overactivity in men with lower urinary tract symptoms secondary to benign prostatic hyperplasia J Urol 1744Pt1 1327 1333 (Pubitemid 41318722)
41. G.E. Alvarez S.D. Beske T.P. Ballard K.P. Davy 2002 Sympathetic neural activation in visceral obesity Circulation 106 2533 2536 (Pubitemid 35340687)
42. K.P. Davy J.S. Orr 2009 Sympathetic nervous system behavior in human obesity Neurosci Biobehav Rev 33 116 124
43. E.A. Platz I. Kawachi E.B. Rimm 1998 Physical activity and benign prostatic hyperplasia Arch Intern Med 158 2349 2356 (Pubitemid 28536488)
44. J.B. Meigs B. Mohr M.J. Barry 2001 Risk factors for clinical benign prostatic hyperplasia in a community-based population of healthy aging men J Clin Epidemiol 54 935 944 (Pubitemid 32771319)
45. S. Rohrmann C.J. Crespo J.R. Weber 2005 Association of cigarette smoking, alcohol consumption and physical activity with lower urinary tract symptoms in older American men: findings from the third National Health and Nutrition Examination Survey BJU Int 96 77 82 (Pubitemid 40942873)
46. N. Orsini B. Rashidkhani S.O. Andersson 2006 Long-term physical activity and lower urinary tract symptoms in men J Urol 176 2546 2550 (Pubitemid 44665949)
47. P.T. Williams 2008 Effects of running distance and performance on incident benign prostatic hyperplasia Med Sci Sports Exerc 40 1733 1739
48. I.W. Mills A. Crossland A. Patel H. Ramonas 2007 Atorvastatin treatment for men with lower urinary tract symptoms and benign prostatic enlargement Eur Urol 52 503 509 (Pubitemid 46963443)
49. A. Descazeaud M.A. Rubin M. Hofer 2008 BPH gene expression profile associated to prostate gland volume Diagn Mol Pathol 17 207 213
50. R. Konwar N. Chattopadhyay H.K. Bid 2008 Genetic polymorphism and pathogenesis of benign prostatic hyperplasia BJU Int 102 536 544
51. D. Ornish M.J.M. Magbanua G. Weidner 2008 Changes in prostate gene expression in men undergoing an intensive nutrition and lifestyle intervention Proc Natl Acad Sci USA 105 8369 8374 (Pubitemid 351904762)